Kilitch Drugs (India) Limited has informed the Exchange that Board of Directors at its meeting held on July 12, 2025, has decided to issue equity shares on rights basis in the ratio of 2 : 23, i.e 2 Equity Shares for every 23 Equity Shares held. Issue Price is 357 per share.
KILITCH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Kilitch Drugs (India) Limited, at its meeting held on July 12, 2025, approved a Rights Issue of equity shares to existing shareholders. The issue is in the ratio of 2 equity shares for every 23 equity shares held, at a price of ₹357 per share. The Rights Issue will open on July 23, 2025, with the last date for renunciation being September 01, 2025, and the closing date being September 04, 2025. The Rights Entitlement number is 1729020010. Existing shareholders will receive a Letter of Offer detailing the issue.
Eligible shareholders will have the opportunity to buy additional shares at ₹357 per share in the defined ratio. Shareholders who do not wish to subscribe can renounce their rights by September 01, 2025. The issue may lead to short-term dilution of equity, and the stock could see price adjustment (ex-rights) around the record date.